EurekAlert! -
26 Jun 2019 06:00
(University of Illinois at Chicago) Researchers at the University of Illinois at Chicago and AbbVie Inc. have developed a novel device that will help scientists and pharmaceutical companies more effectively screen and test formation of drug substance -- active pharmaceutical ingredient (API).
Share this Article
Comment on this Article
Please to comment